2008
DOI: 10.1016/j.neuropharm.2008.06.005
|View full text |Cite
|
Sign up to set email alerts
|

Anticataleptic 8-OH-DPAT preferentially counteracts with haloperidol-induced Fos expression in the dorsolateral striatum and the core region of the nucleus accumbens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
29
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 40 publications
(32 citation statements)
references
References 28 publications
2
29
0
Order By: Relevance
“…1,[3][4][5] Several studies demonstrated that activation of 5-HT 1A receptors improves antipsychotic-induced EPS and motor disabilities in animal models of Parkinson's disease. [10][11][12][13][14][15][16] In our studies, 5-HT 1A agonists (e.g., 8-hydroxy-2-(di-n-propylamino)-tetralin and tandospirone) ameliorated haloperidol-induced bradykinesia and catalepsy with potencies similar to those of antiparkisonian agents (e.g., trihexyphenidyl and L-3,4-dihydroxyphenylalanine (L-DOPA)). 13,14) Consistently with these anti-EPS actions, 5-HT 1A agonists reversed striatal Fos protein expression induced by haloperidol, indicating that 5-HT 1A receptors counteract D 2 receptor blockade by antipsychotics in the striatum.…”
Section: Roles Of 5-ht Receptors In Modulating Extrapyramidal Motor Dmentioning
confidence: 57%
See 2 more Smart Citations
“…1,[3][4][5] Several studies demonstrated that activation of 5-HT 1A receptors improves antipsychotic-induced EPS and motor disabilities in animal models of Parkinson's disease. [10][11][12][13][14][15][16] In our studies, 5-HT 1A agonists (e.g., 8-hydroxy-2-(di-n-propylamino)-tetralin and tandospirone) ameliorated haloperidol-induced bradykinesia and catalepsy with potencies similar to those of antiparkisonian agents (e.g., trihexyphenidyl and L-3,4-dihydroxyphenylalanine (L-DOPA)). 13,14) Consistently with these anti-EPS actions, 5-HT 1A agonists reversed striatal Fos protein expression induced by haloperidol, indicating that 5-HT 1A receptors counteract D 2 receptor blockade by antipsychotics in the striatum.…”
Section: Roles Of 5-ht Receptors In Modulating Extrapyramidal Motor Dmentioning
confidence: 57%
“…13,14) Consistently with these anti-EPS actions, 5-HT 1A agonists reversed striatal Fos protein expression induced by haloperidol, indicating that 5-HT 1A receptors counteract D 2 receptor blockade by antipsychotics in the striatum. 14,15) Earlier studies showed that microinjection of 5-HT 1A agonists into the raphe nuclei attenuated antipsychotic-induced catalepsy, suggesting that activation of presynaptic 5-HT 1A autoreceptors can reduce EPS 11) ( Fig. 1 and Table 1).…”
Section: Roles Of 5-ht Receptors In Modulating Extrapyramidal Motor Dmentioning
confidence: 69%
See 1 more Smart Citation
“…The catalepsy test was carried out as described previously (10). Briefly, the fore paws of the animals were placed on a horizontal bar positioned at 5 cm above the bench surface, and the time spent for the animals to show the cataleptic posture, which was defined as an immobile posture while keeping both forelimbs on the bar, was measured with a maximum limit of 30 s.…”
Section: Catalepsy Testmentioning
confidence: 99%
“…Consistent with previous findings (4,7,9), our results suggest that 8-OH-DPAT alleviates APD-induced EPS probably through activating postsynaptic 5-HT 1A receptors (including heteroreceptors). In addition, anticataleptic 8-OH-DPAT reversed the haloperidol (D 2 antagonism)-induced Fos expression in the dorsolateral striatum (dlST) and the core region of the nucleus accumbens (AcC), without affecting other brain regions examined (10). Thus, it was suggested that stimulation of 5-HT 1A receptors could reduce the D 2 -blocking actions of APDs specifically in brain regions (i.e., dlST and AcC) that are related to EPS induction (11 -13).…”
Section: Introductionmentioning
confidence: 99%